Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09YXV
|
||||
| Former ID |
DNC004687
|
||||
| Drug Name |
3-[5-Methoxy-indan-(1E)-ylidenemethyl]-pyridine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [527456] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C16H15NO
|
||||
| Canonical SMILES |
COC1=CC2=C(C=C1)C(=CC3=CN=CC=C3)CC2
|
||||
| InChI |
1S/C16H15NO/c1-18-15-6-7-16-13(4-5-14(16)10-15)9-12-3-2-8-17-11-12/h2-3,6-11H,4-5H2,1H3/b13-9+
|
||||
| InChIKey |
HVRLSDXXVKSVBR-UKTHLTGXSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cytochrome P450 19 | Target Info | Inhibitor | [527456] | |
| Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [527456] | ||
| NetPath Pathway | FSH Signaling Pathway | ||||
| PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
| PathWhiz Pathway | Androgen and Estrogen MetabolismPW000141:Steroidogenesis | ||||
| WikiPathways | Metapathway biotransformation | ||||
| Tryptophan metabolism | |||||
| Oxidation by Cytochrome P450 | |||||
| Ovarian Infertility Genes | |||||
| Metabolism of steroid hormones and vitamin D | |||||
| FSH signaling pathway | |||||
| Integrated Breast Cancer Pathway | |||||
| Phase 1 - Functionalization of compoundsWP702:Metapathway biotransformation | |||||
| Corticotropin-releasing hormone | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.